Yanmei Yang

100 Kexue Road
Zhengzhou, 450001, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Integrative 3D genome and epigenomic analysis identifies TP53RK and SYBU as critical regulators of stemness and anti-tumor immunity in HCC.

Integrative 3D genome and epigenomic analysis identifies TP53RK and SYBU as critical regulators of stemness and anti-tumor immunity in HCC.

Journal: Cell reports
Published: February 10, 2026

EPS8L2 drives colorectal cancer cell proliferation and migration via YBX1-dependent activation of G3BP2 transcription.

EPS8L2 drives colorectal cancer cell proliferation and migration via YBX1-dependent activation of G3BP2 transcription.

Journal: Cell death & disease
Published: February 13, 2025

CPNE7 promotes colorectal tumorigenesis by interacting with NONO to initiate ZFP42 transcription.

CPNE7 promotes colorectal tumorigenesis by interacting with NONO to initiate ZFP42 transcription.

Journal: Cell death & disease
Published: July 31, 2024

PELI2 inhibits colorectal cancer development through MAPK signaling pathway.

PELI2 inhibits colorectal cancer development through MAPK signaling pathway.

Journal: Molecular medicine (Cambridge, Mass.)
Published: June 23, 2024

Enteric GABAergic neuron-derived γ-aminobutyric acid initiates expression of Igfbp7 to sustain ILC3 homeostasis.

Enteric GABAergic neuron-derived γ-aminobutyric acid initiates expression of Igfbp7 to sustain ILC3 homeostasis.

Journal: Nature immunology
Published: March 21, 2024

CCDC113 promotes colorectal cancer tumorigenesis and metastasis via TGF-β signaling pathway.

CCDC113 promotes colorectal cancer tumorigenesis and metastasis via TGF-β signaling pathway.

Journal: Cell death & disease
Published: March 05, 2024

Lipolysis engages CD36 to promote ZBP1-mediated necroptosis-impairing lung regeneration in COPD.

Lipolysis engages CD36 to promote ZBP1-mediated necroptosis-impairing lung regeneration in COPD.

Journal: Cell reports. Medicine
Published: December 07, 2023

CRISPR-Cas9 screening identifies INTS3 as an anti-apoptotic RNA-binding protein and therapeutic target for colorectal cancer.

CRISPR-Cas9 screening identifies INTS3 as an anti-apoptotic RNA-binding protein and therapeutic target for colorectal cancer.

Journal: iScience
Published: December 03, 2023
Showing 1-8 of 8

Last Updated: 09/26/2026